deCODE genetics Inc  (DCGN) Trade Now »     Rate DCGN  -  Discuss DCGN  -  Add to Watch List        

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

DCGN: Bull or Bear?

From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Bullish on DCGN ... DCGN

76%

+18.92% in 3 days (closed on 11/10/08) I think DCGN is trading at the bottom of a range. In the long term I think they're done, but yesterday's 32% decline was just unfair. Continue reading »

Talk about missing the boat... DCGN

76%

+16.50% in 15 hours (closed on 10/09/08) I saw the news before hours deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer . Unfortunately all of my funds were locked up in OTCs that are untradable before market hours. So I figured that I missed the boat on this one. I didn't consider, however, that in a market like this folks will jump all over this type of release.  Now I see the stock at $.75 after hours and I could have bought four $.40 at the opening.  So we'll add this one to my personal wall of shame along with the two ten baggers WB (on the judgement da... Continue reading »

biotech lotto ticket DCGN

69%

-10.95% in 9 days (closed on 03/15/08) huge gamble, but popularity of DNA testing is increasing, they have a lot of data on a fairly unique population, could result in a lotto drug or testing results.........don't invest more than you can afford to lose! Continue reading »

From the Blogosphere

deCODE to Trade Sideways DCGN

-67.03% in 495 days We would like to remain on the sidelines and await a partnership announcement for one or more of the clinical candidates. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see... Continue reading »

Pre-Market Gappers

Gapping up: WX +19.0%, EFUT +17.2%, FMT +7.9%, GSIC +6.9%, FRE +6.4%, TBSI +5.2%, AIRM +4.8%, OME +3.6%, GEOY +2.7%, TTWO +2.4%, BMTI +2.2%, UNH +1.9%, TGT +1.8%, EXM +1.8%, NMX +1.7%, EGLE +1.3%, BVF +1.1%... Gapping down: ATAR -34.0%, SUF -26.8%, VM -19.0%, SIGM -14.4%, MW -9.0%, NGAS -8.6%, JAS -4.8%, BSC -4.5%, PTR -4.4%, BIDU -2.9%, CFC -2.1%, DCGN -2.1%, BG -2.1%, MER -1.9%, C -1.8%, ING -1.7%, UBS -1.7%, GS -1.2%. Continue reading »

Fiday's Upgrades and Downgrades

2 %

<> UPGRADES Occidental Petro (OXY)= BMO Capital Markets Market Perform » Outperform Magna (MGA)= RBC Capital Mkts Sector Perform » Outperform Odyssey Healthcare (ODSY)= Leerink Swann Mkt Perform » Outperform Comtech (COGO)= Needham & Co Buy » Strong Buy Hi-Tech Pharma (HITK)= FTN Midwest Neutral » Buy NYMEX (NMX)= BMO Capital Markets Market Perform » Outperform Quiksilver (ZQK)= Morgan Keegan Mkt Perform » Outperform Tesoro (TSO)= BMO Capital Markets Market Perform » Outperform Stryker (SYK)= Wachovia Mkt Perform » Outperform Boeing (BA)= Bernstein ... Continue reading »

Fiday's Upgrades and Downgrades

<> UPGRADES Occidental Petro (OXY)= BMO Capital Markets Market Perform » Outperform Magna (MGA)= RBC Capital Mkts Sector Perform » Outperform Odyssey Healthcare (ODSY)= Leerink Swann Mkt Perform » Outperform Comtech (COGO)= Needham & Co Buy » Strong Buy Hi-Tech Pharma (HITK)= FTN Midwest Neutral » Buy NYMEX (NMX)= BMO Capital Markets Market Perform » Outperform Quiksilver (ZQK)= Morgan Keegan Mkt Perform » Outperform Tesoro (TSO)= BMO Capital Markets Market Perform » Outperform Stryker (SYK)= Wachovia Mkt Perform » Outperform Boeing (BA)= Bernstein ... Continue reading »

DCGN will trend sideways as investors wait for more information about the company's pipeline.

28%

DCGN will trend sideways as investors wait for more information about the company's pipeline. Continue reading »

... more »  

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.